Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC Ltd : World’s leading Event Organizer

Conference Series LLC Ltd Conferences gaining more Readers and Visitors

Conference Series LLC Ltd Web Metrics at a Glance

  • 3000+ Global Events
  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Stroke Meet 2019

About Conference


ME Conferences is overwhelmed to announce the commencement of 6th Annual Conference on Stroke and Neurological Disorders to be held on September 23-24, 2019 at Dubai, UAE with the innovative theme “New Emerging Drifts and Tactic on Stroke and Neurological Disorders”.

 ME Conferences organizes a series of conferences of 1000+ international Events inclusive of 1000+ Conferences, 500+ future and former Symposiums and Workshops in USA, Europe & Asia with support from a thousand additional scientific societies and publishes 700+ Open access Journals that contains over 50000 eminent personalities, acknowledged scientists as editorial board members

This innovative conference discusses the directions of Neurological Disorders, Stroke with advanced Neuroscience in this fast moving and developing science and technology. Annual Conference on Stroke and Neurological Disorders provides the scope for opportunities to learn about latest technologies, medical practices and mainly focuses on spreading the awareness about how to prevent stroke and neurological disorders and various challenges in the field of neuroscience.

 We are awaiting a great gathering of scientists, research scholars, surgeons, physicians, scientific faculty, pharmaceutical industries, manufacturers and more audience from Dubai, UAE as well as other continents and expect a highly interesting scientific as well a representative event.

WHY TO ATTEND?

STROKE MEET 2019 provides the best platform to learn, inform and discuss new ideas, current discoveries, medications, failures and issues related to neurological disorders as well as stroke and is progressed by knowledgeable, skilled and experienced  Neurologists, neuroscientists, neuro health professionals, neurology nurses and hospitals, stroke specialists, neuro-researchers, neuro health care associates, pharmaceutical companies and a team of many other multidisciplinary specialists and medical device manufacturing company. Stroke Meet 2019 Conference aims in gathering worldwide experts and eminent people to share and discuss their novel ideas and research work so that it would be beneficial for patients suffering from stroke and neurological disorders. Stroke Meet 2019 objective is to gather the audience from everywhere throughout the world to present current research and to disseminate the new trends in the field of stroke and neurology.

It will be a great platform for the young budding researchers and delegates to breakout sessions, highlighting clinical projects, education, and research studies and also to gain immense knowledge from the Conference with the Neurologists.

We likewise respect the cooperation of scientists, research scholars, surgeons, physicians, science faculty and more audience, Presidents, CEO's, Delegates and Industrial administrators from Pharmacy and Health care divisions making the meeting an ideal stage to arrange, share perspectives and information through interactive keynote, plenary, posters and B2B discussions.

TARGET AUDIENCE

  • Neurologists
  • Neurosurgeons Pharmacists
  • Neurology Nurses
  • Specialists in neuroscience medicine
  • Academic Professionals
  • Research Scholars
  • Pharmaceutical Companies
  • Primary care doctors
  • Primary care professionals  
  • Nurses
  • Students
  • Associations and Societies
  • Physicians and Faculty
  • Medical Colleges
  • Neurorehabilitation Physicians
  • Training Institutes
  • Manufacturing Medical Devices Companies
  • Hospital Administrators
  • Hospital General Counsel
  • Business Delegates
  • Neurology Faculty and Students

Sessions/ Tracks

Track 1: Stroke and Mental Health

Though the effects of stroke are unpredictable, mood disorders such as depression, anxiety and pseudo-bulbar affect (PBA) are equally common. Researchers are actively investigating if certain kinds of strokes or strokes in certain areas of the brain produce mood disorders. So far, studies suggest that simply having a stroke increases the risk of either anxiety or depression, or having both. Research indicates that PBA is more common in survivors of the brainstem stroke, but it can occur in strokes in other areas. Depression affects between one- and two-thirds of stroke survivors. It’s characterized by feelings of overarching sadness, lack of pleasure in activities that were before enjoyed, or changes in eating and sleeping patterns. On other hands, anxiety occurs when a survivor focuses on worries and concerns. “They go over them again and again in their minds but without necessarily reaching a conclusion.  Anxiety affects about 20 per cent of survivors.  PBA is characterized by a mismatch between feelings and expression – laughing at a funeral, crying at a joke. PBA hasn’t been investigated as much as depression or anxiety, but it’s not uncommon, impacting 28 to 52 per cent of stroke survivors, according to studies. Mood disorders significantly alter the lives of survivors and their families. Because crying or a lack of emotions characterize the disorders, it’s best to identify them accurately and receive treatment based on a psychological assessment. A mental health professional talks with the survivor to determine their internal state of mind and their behaviour.

Track 2: Neurological Disorders

According to a survey, there are more than 600 neurological disorders. Neurological disorders are diseases that affect the brain and the central and autonomic nervous systems. In recognizing the signs and symptoms of neurological problems, it is first important to differentiate the many types of neurological disorders. The World Health Organization reports that various types of neurological disorders affect millions of people around the world, including 24 million that suffer from Alzheimer’s disease and 326 million who experience migraines. If you suspect that you or a loved one may be suffering from one of these issues, you may also be wondering about what causes a neurological disorder. The causes of such dysfunction can be quite diverse. Both the spinal cord and brain are insulated by abundant membranes that can be vulnerable to force and pressure. The peripheral nerves located deep under the skin can also be vulnerable to damage. Neurological disorders can affect a whole neurological pathway or a single neuron. Even a small disturbance to a neuron’s structural pathway can result in dysfunction

Track 3: Stroke and Cardiovascular Diseases

Cerebrovascular disease is a medical condition that affects the blood vessels of the brain and the cerebral circulation. The arteries supplying oxygen and nutrients to the brain are usually getting damaged in these disorders. The most common type of cerebrovascular disease is an ischemic stroke or mini-stroke and sometimes a haemorrhagic stroke. High blood pressure (Hypertension) is the most important contributing risk factor for stroke and cerebrovascular diseases as it can change the structure of blood vessels and result in atherosclerosis. Atherosclerosis is a condition where the blood vessels narrow in the brain, resulting in decreased cerebral perfusion. Narrowed cerebral arteries may lead to ischemic stroke, but continually elevated blood pressure can also cause tearing of vessels, leading to a haemorrhagic stroke. Stroke is a risk factor for coronary heart disease. Coronary heart disease and stroke share many of the same risk factors such as high LDL (“bad”) cholesterol levels, low HDL (“good”) cholesterol levels, high blood pressure, smoking, diabetes, physical inactivity, and being overweight or obese. Individuals with coronary heart disease, angina, or who have had a heart attack due to atherosclerosis, have more than twice the risk of stroke than those who haven’t. If you have atherosclerosis in the coronary arteries you are very likely to have atherosclerosis in other parts of your body. Atherosclerosis is often referred to as "hardening of the arteries." The word comes from the Greek words athero (meaning gruel or paste) and sclerosis (hardness). In atrial fibrillation, the upper chambers of the heart (the atria) quiver instead of beating effectively to move blood into the ventricle.

Track 4: Brain and Neuromuscular Diseases

A healthy brain and nervous system control your body functions so you can have full command over your senses, muscles, and intelligence. Despite the amazing capacities of the human brain and nerves, they are vulnerable to damage just like every other part of our bodies. Strokes, concussions, Alzheimer’s and many other brain problems affect about 50 million Americans. The multitude of brain injuries and illnesses strike different people based on the risk factors of their genetics, age and lifestyle. The severity of impairment and the availability of treatment vary widely. Knowledge of brain and nerve health has advanced rapidly in recent decades. Many new treatments and medicines are available to treat various disorders. Still, the best thing for your brain is to keep it physically and mentally active while eating nutritious food and getting plenty of social interaction. Neuromuscular diseases are a wide-ranging group of diseases that affect nerves and muscles. They can arise following an injury, from other diseases such as diabetes, or from inherited or autoimmune diseases. Neuromuscular diseases can cause pain, weakness, numbness, and sometimes more severe symptoms such as difficulty talking, eating, or breathing. Neuromuscular diseases include Amyotrophic lateral sclerosis (Lou Gehrig's Disease), Guillain Barre syndrome, Muscular dystrophy, Myasthenia gravis, Myopathy.

Track 5: Stroke Rehabilitation and Recovery

Rehabilitation is given for a long period of time to improve function so that the stroke survivor can become as independent as possible. This must be accomplished in a way that preserves dignity and motivates the survivor to relearn basic skills that the stroke may have impaired - skills like bathing, eating, dressing and walking. Rehabilitation starts in the hospital as soon as possible following a stroke. The rehab team includes Physiatrist, Neurologist, Rehabilitation Nurse, Physical Therapist, Occupational Therapist and Speech-Language Pathologists. Recovery following a stroke starts as the brain responds to what’s happened. The brain’s functions will be adjusted to account for the death or decrease in the affected area. If a stroke victim receives medical attention within three hours of suffering the stroke they may be a candidate to receive medication to break up clots via an IV-drip. This clot-destroying medicine can significantly reduce negative long-term disabilities in the patient. The rehabilitation process begins after doctors have assessed and treated any critical conditions in the patient, and taken precautionary steps to prevent additional complications. This means rehabilitation could begin during the patient’s first hospital visit, which will increase the likelihood of recovering the damaged body and brain function. The first three months of recovery are when a patient will see the most development, and gains may happen rapidly over time. Some stroke survivors will continue to progress after this period; however, if the brain stem was affected during the stroke recovery could take up to a year or even longer

Track 6: Epidemiology

Epidemiology is a scientific discipline with sound methods of scientific inquiry at its foundation. Epidemiology is data-driven and relies on a systematic and unbiased method to the collection, analysis, and clarification of data. Basic epidemiologic methods tend to rely on the careful remark and use of valid comparison groups to assess whether what was observed, such as the number of cases of the disease in a specific area during a specific time period or the frequency of an exposure among persons with the disease, differs from what might be expected. However, epidemiology also draws on methods from other scientific fields, including biostatistics and informatics, with biologic, economic, social, and behavioural sciences. In fact, epidemiology is often described as the basic science of public health, and for good reason. First, epidemiology is a quantitative discipline that relies on a working knowledge of probability, statistics, and sound research methods. Second, epidemiology is a method of causal intellectual based on developing and testing hypotheses grounded in such scientific fields as biology, behavioural sciences, physics, and ergonomics to explain health-related behaviours, states, and events. However, epidemiology is not just a research activity but an integral component of public health, providing the foundation for directing practical and suitable public health action based on this science and causal reasoning.

Track 7: Neurophysiology and Neurodegeneration

Neurophysiology is a branch of physiology and neuroscience that is concerned with the study of the functioning of the nervous system. The primary tools of basic neurophysiological research include electrophysiological recordings, for example, voltage clamp, patch clamp, extracellular single-unit recording and recording of local field potentials, as well as some of the methods of apoptogenesis, calcium imaging, and molecular biology. Neurophysiology is related to electrophysiology, neuroanatomy, psychology and mathematical neuroscience. Neurodegeneration is the process of progressive damage of structure or function of neurons, with the death of neurons. Many neurodegenerative diseases – including amyotrophic lateral sclerosis, Parkinson's, Alzheimer's, and Huntington's – occur as a result of neurodegenerative processes. Such diseases are incurable, resulting in progressive degeneration and/or death of neuron cells. As research progresses, many similarities appear that relate these diseases to one another on a sub-cellular level. Discovering these resemblances offers hope for therapeutic advances that could ameliorate many diseases simultaneously. There are many parallels between different neurodegenerative disorders including atypical protein assemblies as well as induced cell death. Neurodegeneration can be found in many different levels of neuronal circuitry ranging from molecular to systemic.

Track 8: Brain Tumor and Neuro-oncology

Benign and malignant. Benign tumors are usually formed by slow-growing cells that hardly spread. Though they can press on and damage nearby normal tissue, benign tumors are less dangerous than malignant tumors. However, they can be dangerous if they endanger vital brain centres. However, over time, some benign tumors can become malignant. Malignant brain tumors, on the other hand, are formed by cells that typically grow quickly and are capable of invading nearby tissues and spreading to other parts of the body. Their tendencies to attack and spread make these tumors much more dangerous. Malignant tumors of the brain often spread to other parts of the central nervous system. Only relatively few spread to other parts of the body. The cause of most brain cancers is unknown. In general, cancers are due to a combination of inherited genetic factors coupled with some exposure during life, such as exposure to a chemical, a virus or radiation. Of these, the best case has been made for exposure to high doses of radiation, such as those given as part of cancer treatment, and an increased risk of subsequent brain cancer. Exposure to some chemicals in the workplace has also been found to increase the risk of developing brain cancer. Infections may play a role as well: the virus that causes mononucleosis, the Epstein-Barr virus, has been linked to an increased risk of a form of lymphoma that affects the central nervous system, CNS lymphoma, which also is more common among individuals infected with HIV, the virus that causes AIDS. Genetics play a particularly important role in a number of brain tumors that are clearly linked to a number of inherited disorders and disorders due to chromosome injury.

Track 9: Neuroplasticity

The recent neuroscience research proves that Neuroplasticity is the basis for brain working out exercises which revolutionized the brain health and science research. The ability of the Brain to alter at any age is referred to as Neuroplasticity or Brain Plasticity. There are about 600 Neurological disorders and approximately 50 million Americans are being affected each year. The main risk factors for Neurological disorders are genetic manipulation, age, lifestyle and other eco-friendly agents. Abnormalities in structural and biochemical functions cause various symptoms. Some of them are paralysis, seizures, confusion, muscle weakness and altered levels of consciousness. One of the fundamental principles underlying neuroplasticity is based on the idea that individual synaptic contacts are constantly being removed or recreated, largely dependent upon the activity of the neurons that bear them. The activity-dependence of synaptic plasticity is captured in the aphorism which is often used to summarize Hebbian theory: "neurons that fire together, wire together"/"neurons that fire out of sync, fail to link". If two nearby neurons often produce an impulse in close temporal proximity, their functional properties may converge. Conversely, neurons that are not regularly activated simultaneously may be less likely to functionally converge.

Track 10: Neuroprotection

Neuroprotection suggests to the relative storing of neuronal structure and/or function. In the case of an on-going insult (a neurodegenerative insult), the relative preservation of neuronal integrity implies a decreasing in the rate of neuronal loss over time, which can be expressed as a differential equation. It is a widely explored treatment option for many central nervous system (CNS) disorders including neurodegenerative diseases, spinal cord injury, stroke, traumatic brain injury and acute management of neurotoxin consumption (i.e. methamphetamine overdoses). Neuroprotection aims to prevent or slow disease progression and secondary injuries by halting or at least slowing the loss of neurons. In spite of contrasts in indications or wounds related to CNS clutters, numerous of the instruments behind neurodegeneration are the same. Common instruments incorporate expanded levels in the oxidative stretch, mitochondrial brokenness, excitotoxicity, provocative changes, press amassing, and protein aggregation. Of these instruments, neuroprotective medications regularly target oxidative stretch and excitotoxicity—both of which are greatly related with CNS disarranges. Not as it was can oxidative stretch and excitotoxicity trigger neuron cell passing but when combined they have synergistic impacts that cause indeed more debasement than on their own. In this way restricting excitotoxicity and oxidative push may be an exceptionally vital perspective of neuroprotection. Common neuroprotective medications are glutamate opponents and cancer prevention agents, which point to constrain excitotoxicity and oxidative.

Track 11: Neuroimmunology and Neurotransmitters

Neuroimmunology is a field combining neuroscience, the study of the nervous system, and immunology, the study of the immune system. Neuroimmunologists seek to better understand the interactions of these two complex systems during development, homeostasis and answer to injuries. A long-term aim of this rapidly developing research area is to further develop our understanding of the pathology of certain neurological diseases, some of which have no clear aetiology. In doing so, neuroimmunology contributes to the development of new pharmacological treatments for several neurological conditions. Many kinds of interactions involve both the nervous and immune systems including the physiological functioning of the two systems in health and disease, malfunction of either and or both systems that lead to disorders and the physical, chemical, and ecological stressors that affect the two systems on a daily basis. Neurotransmitters are endogenous chemicals that enable neurotransmission. It is a type of chemical messenger which transmits signals across a chemical synapse, such as a neuromuscular connection, from one neuron (nerve cell) to another "target" neuron, muscle cell, or gland cell. Neurotransmitters are released from synaptic vesicles in synapses into the synaptic cleft, where they are received by neurotransmitter receptors on the target cells. Many neurotransmitters are synthesized from simple and abundant precursors such as amino acids, which are readily available from the diet and only require a small number of biosynthetic steps for conversion. Neurotransmitters play a major role in shaping everyday life and functions. Their exact numbers are unknown, but more than 200 chemical messengers have been uniquely identified.

Track 12: Pediatric Stroke and Recovery

The major reason of death in children in the USA  is due to stroke and the most pediatric stroke survivors will be suffering from neurological or cognitive impairments. Because of the plasticity of the brains of children, they recover earlier than adults. A stroke survivor may be diagnosed with Epilepsy. Based on the cause of the stroke, the treatments will be decided by the physicians. Constraint therapy is an old therapy, but it is now widely used in pediatric stroke rehabilitation. If the stroke is caused by the blockage, then blood thinning medications will be given. If a stroke occurs due to Sickle Cell Disease (SCD), then an immediate blood transfusion will be performed. A physiotherapist can help with movement problems such as weakness or paralysis, spasticity or muscle spasms.  The therapist will assess and design a program to increase muscle strength (which can reduce the risk of spasticity) and movement. It is estimated that about 6 million deaths are due to cerebrovascular disorders. It is the second leading cause of death in the world and 6th most common cause of disability.

Track 13: Neuropsychiatry

Neuropsychiatry preceded the current disciplines of psychiatry and neurology, which had common training; however, psychiatry and neurology have subsequently split apart and are typically practised separately. Neuropsychiatry is thoroughly associated with the fields of behavioural neurology. Neuropsychiatry is the interface of Psychiatry and Neurology that deals with mental disorders, which in most cases can be shown to have their origin from an identifiable brain malfunction. Neuropsychiatry focuses to understand the link between the mind, body and its behaviour. Training in both neurological and psychiatric aspects of illness places Neuropsychiatry in a unique place to deliver this care. An effective evaluation of the clinical course of diseases requires the application of very precise diagnostic and assessment approaches as early as possible. By achieving these strategies, offers new chances for biomarker identification and/or discovery in complex diseases and may provide pathological pathways understanding for diseases beyond traditional methodologies.

Track 14: Stroke Nursing and Interventions

Nurses play an important role in all phases of care of the stroke patient. Some of the nurse caring plans are Ineffective Cerebral Tissue Perfusion, Impaired Physical Mobility, Impaired Verbal Communication, Disturbed Sensory Perception, Ineffective Coping, Self-Care Deficit, and Risk for Reduced Swallowing. Nurses may work as an emergency medical specialist (EMT) and paramedics, radio providers of online medical control to emergency medical services (EMS) personnel from base stations, and educators who teach EMS personnel about stroke and the care of stroke patients. Nurse Interventions are monitoring major signs in patients such as monitoring blood pressure, comparing BP reading in arms, heart rate, rhythm, and murmurs. There also monitor Respirations, noting patterns and rhythm, Cheyne-Strokes respiration

 

Market Analysis

Importance and Scope:

The global neurobiology market size was valued at USD 28.42 billion in 2016 and is predicted to grow at a CAGR of 3.1% over the forecast amount. High influencing factors, like current brain mapping analysis and investigation comes, neuroscience-based initiatives by government bodies, and technological advances in tools and algorithms that are enforced in neurobiology These factors are anticipated to bolster revenue generation by encouragement the merchandise adoption during this market throughout the forecast year.

Presence of organizations & institutes, such as NIH, NeuroScience Canada, University of Utah, Max Planck Florida Institute, Ontario Brain Institute, and the University of Pennsylvania; in the space are expected to majorly impact the development of neuroscience arena. These entities play a crucial role in fast neuroscience-based analysis and development to boost patient outcomes in those full of medicine disorders.

Several initiatives are undertaken by the aid communities to require brain-related studies and innovations a step additional. For instance, in 2014, University of Utah launched the “Neuroscience Initiative” in order to help alleviate the devastating effects of brain disorders. The initiative was created for deepening the understanding of the consequences of brain disorders on health and channelizing the information into innovative solutions for patient care.Continuous introduction of novel merchandise by key participants within the market to combat varied medicine disorders is predicted to spice up Y-O-Y growth of this market.

For instance, in September 2015, Codman Neuro (operation unit of DePuy Synthes) introduced CODMAN CERTAS plus programmable valve, an MRI-resistant programmable valve with eight different pressure settings. This product was introduced hydrocephalus treatment. Furthermore, key factor that has accelerated the research studies in this arena is the growth in number of various malignant CNS disorders such as Parkinsonism and Alzheimer’s disease. As geriatric population is liable to varied central nervous systems associated disorders like schizophrenic disorder, Alzheimer’s, and Parkinsonism, with growth in older population, this market is anticipated to witness lucrative growth. As per the 2017 Alzheimer’s unwellness Facts and Figures printed by Alzheimer’s Association. In 2017, 38 of the full population with Alzheimer’s insanity within the U.S.

Neurology Hospitals in UAE

  • Asala Medical Center
  • Berlin Medical and Neurological Rehabilitation
  • Neuro Spinal Hospital
  • American Center for Psychiatry & Neurology 
  • Burjeel Neuro Rehabilitation and Physiotherapy Center
  • August Medical cereneo Center for Neurological Rehabilitation
  • German Neuroscience Center
  • American Center Psychiatry and Neurology
  • German Neuroscience Center

Age Factor in Stroke:

Associations and societies worldwide:

  • World Federation of Neurology
  • Association of Neurological Surgeons
  • European Federation of Neurological Societies
  • The International Child Neurology Association
  • Education in child neurology: the role of the International
  • Child Neurology Association (ICNA)
  • Child neurology services in Africa
  • Neuropathy Association
  • The brain & behavior research foundation
  • Alzheimer's Association
  • American Academy of Neurology
  • European Neurological Societies
  • Spanish Society of Neurology
  • Major Neurological Associations in Italy
  • Hilarescere Foundation in Italy
  • Italian MS society in Italy
  • Southern Clinical Neurological Society
  • ESNR European Society of Neuroradiology

Associations of Neurology in UK

  • The British Neuropsychiatry association
  • British Neuroscience Association
  • British Neuro-oncology Society
  • Brain Injury Association of London
  • Stroke Association
  • Brain Injury Rehabilitation Trust
  • Royal Society of London
  • Alzheimer's Society
  • Migraine Trust
  • International Headache Society
  • Huntington's disease Association
  • Brain tumor organizations
  • National Brain Tumor Society
  • British neuroscience association
  • British brain tumor association
  • Scottish Association for Mental Health
  • Association for Infant Mental Health
  • National Association for Mental Health
  • The Brain injury association
  • The Neuro Association

Market Growth of Neuroscience:

The global neuroscience market size was valued at USD 28.42 billion in 2016 and is expected to grow at a CAGR of 3.1% over the forecast period. High influencing factors, such as on-going brain mapping research and investigation projects, neuroscience-based initiatives by government bodies, and technological advances in tools and algorithms that are implemented in neuroscience space, are expected to propel the market growth.

Neuroscience Market size by technology 2012-2020 (USD Million)

Universities associated with Neurology and Neurosurgery in World:

  • Stanford University
  • University of California
  • University of South Carolina Beauport
  • University of Helsinki
  • California Institute of Technology
  • Yale University
  • Harvard University
  • University of Pennsylvania
  • University of Chicago
  • The Kavli Institute for Brain Science
  • Cornell University
  • Dalhousie University
  • Leiden University- Neither land
  • Temple University USA
  • University Oklahoma
  • Boston Coll USA
  • Florida International University
  • King Saud University
  • Ain Shams University
  • American University of Beirut
  • Alfaisal University
  • Mansoura University
  • King Abdulaziz University
  • Assiut University
  • University of Edinburgh
  • University of Manchester
  • Cardiff University
  • University of Vermont
  • University of Amsterdam
  • Ghent University
  • Maastricht University
  • University of Melbourne
  • University of Queensland
  • University of New South Wales
  • University of Adelaide
  • University of Sydney
  • United Arab Emirates University
  • Middlesex University, Dubai
  • NYU Abu Dhabi
  • Zayed Universities
  • Kuwait University
  • New York University Abu Dhabi
  • University of Sharjah
  • Abu Dhabi University
  • German Neuroscience Center         

Who to attend:

Neurophysiologists, Neurologists, Paediatric Neurologists, Neurosurgeons, physiatrists, Research scientists, Neurology Organizations, and Epileptologists Pharmaceutical companies, Neuro and CNS drug Industries, Neuroscience associations, Neuroscience  foundations, neuroradiologists,  Professors, Students from Academia in the study of Neurology and Neurophysiology and researchers who utilize neurophysiological techniques and also  knowledge in diagnosing and in treating nervous system disorders, social workers.

Why to attend?

Neuology and Therapeutics is a unique forum to bring together worldwide distinguished academics in the field of neuroscience and neurology, Brain researchers, public health professionals, scientists, academic scientists, industry researchers, scholars to exchange about state of the art research and technologies.Aim of this conference is stimulate new ideas for treatment that will be beneficial across the spectrum of Brain disorders.

Global Market Analysis of Stroke and Neurological Disorders:

The market analysis of  stroke and neurology represent the largest and untapped market in medicine sector. This estimated market analysis is based on probability of approval and sales of products in late stage development, demographic trends and marketing of product. Emerging markets once again helps to boost revenues. CNS therapeutics comprise approximately 15% of total pharmaceutical sales, nearly $30 billion worldwide.

An estimated annual economic costs of anxiety disorders, depression, and schizophrenia are $47 billion, $44 billion, and $33 billion per year approximately. The goal of this session is to understand the market Value & Growth of Neurology Drugs , Current economics cost of clinical research and development.

Fig: Global analysis of stroke and neurological disorders.

 

 

Associations:

USA:

American Stroke Association | National Stroke Association | Heart and Stroke Foundation of Canada | North Carolina Stroke Association | American Association of Neurological Surgeons | American Academy of Neurology | Canadian Stroke Consortium | Canadian Stroke Network | Intermountain Stroke Center | National Stroke Association | Merican Society of Neuro-rehabilitation | USAAneurysm Foundation& Brain Injury Association of America | Huntington's Disease Society of America and Hydrocephalus AssociationUnited Spinal Association& Vascular Birthmarks Foundation | American Society for Neurochemistry | The Canadian Society of Pharmacology and Therapeutics | American Society for Pharmacology and Experimental Therapeutic | Epilepsy Foundation of America.

Europe:

German Stroke Society | European Stroke Organization | World Federation of Neurology | World Stroke Organization | The Brain Injury Association | Mediterranean Stroke Society | European Federation of Neurological Associations | Spanish Society of Neurology | European neurological society | European Academy of Neurology | National Stroke Association of Russian Federation | Central and East European Stroke Society | Romanian National Stroke Association (RNSA) | British Columbia Society of Electroneurophysiology | Technologists Alzheimer Europe | British Columbia Society of Electro Neurophysiology Technologists | British Paediatric Neurology Association | The British Association of Stroke Physicians | Danish Neurological Society |Dutch Society of Neurology | The Association of British Neurologists| British Neuro-Oncology Society;Italian Neurological Society| Italian Stroke Society | British Acoustic Neuroma Association (BANA)(UK)

Asia Pacific & Middle East:

Emirates Neurology Society (EMINS) | Emirates Nursing Association,Emirates Cardiac Society | Association of Neurophysiological Scientists | Iraqi Neurological Association (INA) - Iraq (IQ) | Israel Society for Neuroscience - Israel (IL) Society for Arab Neuroscientists | Middle East Spine Society | Mediterranean Neuroscience Society | North Africa and the Middle East - Society for Neuroscience | The Pan Arab Neurosurgical Society | Emergence of Cognitive Neuroscience in The Middle East | Middle East Neurosurgical Society | The Saudi Critical Care Society;  Walter E. Dandy Neurosurgical Society; Philippine Neurological Association (PNA) | Malaysian Society of Neurosciences | Neurological Society of India | Neurological Surgeon Society of India (NSSI) | Clinical Neuroscience Society Singapore | The Japan Stroke Society | Asian Pacific Society for Neurochemistr | Indian Society of Neuro-Oncology |Indian Pharmacological Society

Past Conference Report

Stroke Meet 2018

5th Annual Conference on Stroke and Neurological Disorders was organized during November12-13, 2018 at Istanbul, Turkey with the support and contribution of the Organizing Committee Members.

Firstly we must thank you for trusting us and participating at Stroke Meet 2018, a global platform to discuss various important aspects of Neurology.

There are infinite reasons to extend our gratitude to you for making the Stroke Meet 2018 outstanding conference. We couldn't have done it without your continuous support and believe towards our organization, which mutually made to achieve Stroke Meet 2018 new heights in the field of Neuroscience.

The conference was marked by the attendance of young and brilliant researchers, business delegates and talented student communities representing more than 15 countries, who have driven this event into the path of success.   

The conference was organized around the theme “Building a Better World without Disorders”. The event implanted a firm relation of upcoming strategies in the field of Novel approaches and Developments in Neurological Disorders and Stroke with the scientific community. The conceptual and applicable knowledge shared, will also foster organizational collaborations to nurture scientific accelerations.

The conference proceedings were carried out through various Scientific-sessions and plenary lectures, of which the following Speakers were highlighted as Keynote speakers Wagih El Masri, Keele University, USA, Umur A Kayabasi, Bahcesehir University, Turkey, Tayfun Uzbay, Uskudar University, Turkey and Yavuz Selim Silay, ICG(Istanbul Consulting Group), Turkey.

The conference witnessed an amalgamation of peerless speakers, Keynote speakers, well-known researchers and delegates who enlightened the crowd with their enviable research knowledge and on various alluring topics related to the field of Neurological Disorders and Stroke through their fabulous presentations at the podium of Stroke Meet 2018.   

Conference series LLC offers its heartfelt appreciation to all the Organizing Committee Members, Chairs and Co-chairs, Speakers, Students, Media Partners, sponsors and Editorial Board Members of Journal of Neurology,  Journal of Brain Disorders & Therapy and  Journal of Brain Tumors & Neurooncology who supported the conference in every aspect for the awe-inspiring exhibition at the venue.

So as a continuation of Stroke Meet 2018, we would like to heartily invite you to our upcoming 6th Annual Conference on Stroke and Neurological Disorders to be held in Abu Dhabi, UAE on November 25-26, 2019.

For 2019 we are expanding our focus towards all aspects of Neurological Disorders and Stroke Re­search findings. Our organizing committee is gearing up with more innovative and explorative sessions to unleash the boundaries of the Neurological Disorders and Stroke.

Your expertise and knowledge in the area of Neurological Disorders and Stroke will provide an oppor­tunity to discuss and respond to a series of questions about the status of advanced Neurological Disorders and Stroke therapeutics.

Stroke is ranked as the second leading cause of death in Dubai. In the Middle East and North Af­rica, stroke is emerging as a major health problem, with the death rate from it will be double by 2030. In 2013 alone, U.A.E. healthcare expenditures reached an estimate of $ 16.8. The healthcare market of the UAE is expected to expand at a CAGR of over 16% during 2011-2014 on back of neurological disorders. About $ 177.5 million revenue generated from medical tourism in 2012, which may rise to $ 710 million by 2020. FDA submitted drug market report on central nervous system disorders which is estimated $78 billion in 2010 and to reach nearly $81.8 billion by 2015. The market survey forecast of neurological disorders is more than $500 billion per year and also the cost of stroke care is expensive too.

We would like to organize this conference with your support to gather all the Neurological Disorders and Stroke researchers in a single platform, hope we will be honoured with your support to organize Stroke 2019 in a grand level, your support will be the key of success for our next year conference.

We look forward to seeing your benign presence with active contribution and support to make this event successful once more.

Once again it’s our pleasure to welcome you to our upcoming 6th Annual Conference on Stroke and Neurological Disorders to be held in Abu Dhabi, UAE on November 25-26,2019.

 

 


Past Reports  Gallery  

To Collaborate Scientific Professionals around the World

Conference Date September 23-24, 2019

For Sponsors & Exhibitors

sponsorships@conferenceseries.com

Speaker Opportunity

Past Conference Report

Supported By

Journal of Neurological Disorders Brain Disorders & Therapy Journal of Tumour Research & Reports

All accepted abstracts will be published in respective Conference Series LLC LTD International Journals.

Abstracts will be provided with Digital Object Identifier by


Keytopics

  • Addiction Psychiatry
  • Alzheimer Disease
  • Aminoacid
  • Amyloid Hypothesis
  • Amyotrophic Lateral Sclerosis
  • Arteries
  • Artherosclerosis
  • Astrocyte
  • Autonomic Neuropathy
  • Benign Tumors
  • Bipolar Disorder
  • Blood-brain Barrier
  • Brain
  • Central Nervous System
  • Cerebral Edema
  • Cerebral Tissue
  • Cerebrovascular
  • Cerebrovascular Disease
  • Cerebrum
  • Cheyne-Stokes Respiration.
  • Coagulation
  • Dementia
  • Depersonalization
  • Depression
  • Diffusion
  • Disorders
  • Endogenous
  • Epidemiological
  • Epidemiology
  • Epilepsy
  • Epylepsy
  • Excitotoxicity
  • Extracellular Fluid
  • FMRI
  • Guillain Barre Syndrome
  • Haemorrhagic Stroke
  • Holistic Psychiatry
  • Homeostasis
  • Hypertension
  • Hypoperfusion
  • Inflammatory
  • Intervention
  • Ischemic Assault
  • Ischemic Stroke
  • Lymohoma
  • Maladies
  • Malignant Tumor
  • Migraines
  • Motor Neuron Diseases
  • MRI
  • Multiple Sclerosis
  • Muscle Cell
  • Nerve
  • Nervous System
  • Neurodegenerative
  • Neurogenesis
  • Neuroimmunological
  • Neuroplasticity
  • Neuroprotection
  • Neuropsychiatry
  • Neurosarcoidosis
  • Oncology
  • Paralysis
  • Parkinson Disease
  • Pediatric
  • Pediatric Stroke
  • Peptides And Purines
  • Peripheral Nervous System
  • Peripheral Neuropathy
  • PET
  • Phobias
  • Physiotherapy
  • Pseudo-bulbar Effect
  • Psychoanalysis
  • Psychopathology
  • Receptors
  • Rehabilitation
  • Sickle Cell
  • Spasticity
  • Spinal Cord
  • Stroke
  • Synapse
  • Synaptic Cleft
  • Tomography
  • Transfusion
  • Vertebral Stenosis